TechTarget, Inc. Investor News: If You Have Suffered Losses in TechTarget, Inc. (NASDAQ: TTGT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire
2025-07-01

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TechTarget, Inc. (NASDAQ: TTGT) resulting from allegations that TechTarget may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased TechTarget securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=38552 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.

WHAT IS THIS ABOUT: After market hours on April 18, 2025, TechTarget filed with the SEC a current report on Form 8-K. In this current report, TechTarget announced that certain previously filed financial statements "should no longer be relied upon due to certain accounting errors[.]" Further, the current report announced that TechTarget's management had identified material errors "relating to certain technical accounting matters associated with goodwill impairment, changes in contingent consideration, and amortization of intangibles, including related tax impacts thereof."

On this news, TechTarget's stock fell 12.7% on April 21, 2025.


WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        case@rosenlegal.com
        www.rosenlegal.com





More from GlobeNewswire
WzrdBot Launches Next-Generation Automated Trading Platform to Help Crypto Traders Secure Consistent Profits in Unpredictable Markets GlobeNewswire
YieldMax® ETFs Announces Distributions on BIGY, RNTY and SOXY GlobeNewswire
Parexel announces appointments of two FDA luminaries – Lola Fashoyin-Aje, M.D., MPH and Tala Fakhouri, Ph.D., MPH – to its Consulting team, further strengthening regulatory, medical and AI expertise GlobeNewswire
Asia-Pacific Crowdfunding Market Forecast Report 2025-2033 | Fueling Entrepreneurial Growth Amid Rising Investor Interest and Digital Access GlobeNewswire
Genesis Research Group Appoints Tim Wright as Executive Vice President, Access and Pricing GlobeNewswire
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development GlobeNewswire
EDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer Status GlobeNewswire
Nokia's new energy innovation venture Enscryb secures partner and first two customers GlobeNewswire
Apellis to Receive up to $300 Million from Royalty Purchase Agreement with Sobi for Ex-U.S. Royalties of Aspaveli® (systemic pegcetacoplan) GlobeNewswire
Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts GlobeNewswire

About Us

Partners

Copyright (C) 2025 BizWire Express All Rights Reserved.